Prediction of anastomotic leakage after esophagectomy for esophageal cancer: a nomogram study integrating systemic inflammation indices and clinical factors - Report - MDSpire
Advertisement
Prediction of anastomotic leakage after esophagectomy for esophageal cancer: a nomogram study integrating systemic inflammation indices and clinical factors
This study developed and validated a predictive model for anastomotic leakage (AL) risk in esophageal cancer patients undergoing esophagectomy. The model incorporates systemic inflammatory markers and clinical variables.
Background
Anastomotic leakage is a significant complication following esophagectomy, impacting patient outcomes and healthcare costs. This study addresses the need for reliable predictive tools in the management of esophageal cancer.
Data Highlights
Predictor
Training Set AUC
Validation Set AUC
Age
0.813
0.763
Neoadjuvant Radiotherapy
CALLY Index
Hypertension
NLR
NMR
PLR
Key Findings
Seven significant predictors of AL were identified: age, neoadjuvant radiotherapy, CALLY index, hypertension, NLR, NMR, and PLR.
The nomogram model showed good discrimination with an AUC of 0.813 in the training set.
The validation cohort demonstrated moderate predictive accuracy with an AUC of 0.763.
Net benefits were consistent across different risk thresholds in decision curve analysis.
AL impacts morbidity, mortality, and healthcare costs in esophageal cancer patients.
Clinical Implications
The developed nomogram may assist in individualizing risk stratification for patients undergoing esophagectomy.
Conclusion
This study presents a validated predictive model for AL risk in esophageal cancer patients.